These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9643442)

  • 1. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.
    Mahmood I
    J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
    Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
    Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
    Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
    J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery.
    Van den Bergh A; Sinha V; Gilissen R; Straetemans R; Wuyts K; Morrison D; Bijnens L; Mackie C
    Clin Pharmacokinet; 2011 Aug; 50(8):505-17. PubMed ID: 21740074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.
    Mahmood I
    J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
    Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
    BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.
    Hutchaleelaha A; Chow HH; Mayersohn M
    J Pharm Pharmacol; 1997 Feb; 49(2):178-83. PubMed ID: 9055191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.
    Mahmood I; Balian JD
    J Pharm Sci; 1996 Apr; 85(4):411-4. PubMed ID: 8901079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor.
    Lave T; Saner A; Coassolo P; Brandt R; Schmitt-Hoffmann AH; Chou RC
    J Pharm Pharmacol; 1996 Jun; 48(6):573-7. PubMed ID: 8832489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.
    Hildebrand M
    Prostaglandins; 1994 Nov; 48(5):297-312. PubMed ID: 7531864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators.
    Mahmood I
    Haemophilia; 2009 Sep; 15(5):1109-17. PubMed ID: 19523109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
    Mahmood I
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
    Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
    J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allometric scaling of marbofloxacin pharmacokinetics: a retrospective analysis.
    Yohannes S; Hossain MA; Kim JY; Lee SJ; Kwak DM; Suh JW; Park SC
    Pol J Vet Sci; 2014; 17(1):99-103. PubMed ID: 24724476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug disposition viewed in terms of the fractal volume of distribution.
    Karalis V; Macheras P
    Pharm Res; 2002 May; 19(5):696-703. PubMed ID: 12069175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
    Sanwald-Ducray P; Dow J
    Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution.
    Gombar VK; Hall SD
    J Chem Inf Model; 2013 Apr; 53(4):948-57. PubMed ID: 23451981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.